Amlodipine/Valsartan



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 65.0%
Prophylaxis 10.0%
Asthma 5.0%
Asthmatic Crisis 5.0%
Dyslipidaemia 5.0%
Hypothyroidism 5.0%
Type 1 Diabetes Mellitus 5.0%
Femoral Neck Fracture 25.0%
Blood Pressure Diastolic Decreased 12.5%
Blood Pressure Inadequately Controlled 12.5%
Cholecystitis 12.5%
Death 12.5%
Diabetes Mellitus 12.5%
Myocardial Infarction 12.5%
Secondary
Hypertension 21.1%
Blood Pressure Increased 8.9%
Anxiety 7.8%
Rheumatoid Arthritis 7.8%
Suicide Attempt 7.8%
Depression 4.4%
Diabetes Mellitus 4.4%
Lyme Disease 4.4%
Migraine 4.4%
Muscle Spasms 4.4%
Pain 4.4%
Product Used For Unknown Indication 3.3%
Blood Cholesterol Abnormal 2.2%
Drug Withdrawal Maintenance Therapy 2.2%
Dysuria 2.2%
Fungal Infection 2.2%
Hypercholesterolaemia 2.2%
Prophylaxis 2.2%
Reflux Oesophagitis 2.2%
Atrial Fibrillation 1.1%
Completed Suicide 8.7%
Death 8.7%
Prostate Cancer 8.7%
Aortic Valve Incompetence 4.3%
Arthralgia 4.3%
Blood Catecholamines Increased 4.3%
Blood Pressure Inadequately Controlled 4.3%
Coma 4.3%
Dizziness 4.3%
Hemiplegia 4.3%
Hepatic Fibrosis 4.3%
Hypotension 4.3%
Hypothermia 4.3%
Oedema Peripheral 4.3%
Orthostatic Hypotension 4.3%
Skin Plaque 4.3%
Throat Tightness 4.3%
Tongue Oedema 4.3%
Toxicity To Various Agents 4.3%
Transaminases Increased 4.3%
Concomitant
Hypertension 33.3%
Diabetes Mellitus 7.2%
Prostate Cancer 7.2%
Type 2 Diabetes Mellitus 5.4%
Blood Cholesterol Increased 5.0%
Induction Of Anaesthesia 3.6%
Atrial Fibrillation 3.2%
Benign Prostatic Hyperplasia 3.2%
Depression 3.2%
Neuralgia 3.2%
Premedication 3.2%
Thrombosis Prophylaxis 3.2%
Colon Cancer 2.7%
Gastrooesophageal Reflux Disease 2.7%
Hypercholesterolaemia 2.7%
Sleep Disorder 2.7%
Hypothyroidism 2.3%
Osteoporosis 2.3%
Pain 2.3%
Arrhythmia 1.8%
Pneumonia 8.9%
Weight Increased 8.9%
Cerebrovascular Accident 7.1%
Hypertension 7.1%
Malaise 7.1%
Septic Shock 7.1%
Nervousness 5.4%
Renal Impairment 5.4%
Anaphylactic Shock 3.6%
Cholestasis 3.6%
Death 3.6%
Gait Disturbance 3.6%
Hyperglycaemia 3.6%
International Normalised Ratio Increased 3.6%
Pain 3.6%
Presyncope 3.6%
Renal Failure 3.6%
Swelling 3.6%
Vestibular Disorder 3.6%
Visual Acuity Reduced 3.6%
Interacting
Hypertension 79.3%
Peripheral Arterial Occlusive Disease 20.7%
Syncope 66.7%
Aortic Valve Sclerosis 16.7%
Sinus Bradycardia 16.7%